A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 268
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : sIBM
Long Form : sporadic inclusion body myositis
No. Year Title Co-occurring Abbreviation
2019 Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis. ALBIA, ANA, CIA, ELISA, IIF, LIA
2019 Determination of cN1A Autoantibodies by Cell-Based Immunofluorescence Cytochemistry. cN1A
2019 Mitochondrial DNA depletion in sporadic inclusion body myositis. mtDNA
2019 PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited. IMNM, MHC, PD-L1
2019 Resistance Exercise Improves Mitochondrial Quality Control in a Rat Model of Sporadic Inclusion Body Myositis. CQ, MQC, RE
2018 Blood-flow restricted resistance training in patients with sporadic inclusion body myositis: a randomized controlled trial. BFR, CONSORT, IBMFRS, pf-SF-36
2018 Challenges in diagnosis and treatment of sporadic inclusion-body myositis. ---
2018 Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis. ---
2018 Electromyographic findings in sporadic inclusion body myositis. MUAP, SA
10  2018 Endoplasmic Reticulum Stress Induces Myostatin High Molecular Weight Aggregates and Impairs Mature Myostatin Secretion. ER
11  2018 Idiopathic inflammatory myopathies in adults: A comparative study of Bohan and Peter and European Neuromuscular Center 2004 criteria. CTD, DM, ENMC, IIMs, IMNM, NM, PM
12  2018 Immunohistochemical and ultrastructural analysis of sporadic inclusion body myositis: a case series. ---
13  2018 Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions. ER, SR, TDP-43
14  2018 Revisiting Pathological Classification Criteria for Adult Idiopathic Inflammatory Myopathies: In-Depth Analysis of Muscle Biopsies and Correlation Between Pathological Diagnosis and Clinical Manifestations. DM, ENMC, IIMs, NAM, NSM, PM
15  2018 Tongue strength in patients with subacute myelo-optico-neuropathy. ALS, SMON
16  2018 Update on Inclusion Body Myositis. ---
17  2018 What is in the Myopathy Literature? ---
18  2018 [Recent Developments in Myositis Syndromes]. ACR, GC, IIM, IVIG
19  2018 [Sporadic Inclusion Body Myositis and Autoantibodies]. NT5C1A
20  2017 A Systematic Review and Meta-Analysis ofPrevalence Studies of Sporadic Inclusion Body Myositis. ---
21  2017 Association study reveals novel risk loci for sporadic inclusion body myositis. ---
22  2017 Botulinum toxin alleviates dysphagia of patients with inclusion body myositis. BoNT-A, CPM
23  2017 Burden of illness and healthcare resource use in United States patients with sporadic inclusion body myositis. ER, US
24  2017 Differential diagnosis of vacuolar muscle biopsies: use of p62, LC3 and LAMP2 immunohistochemistry. NM, OPMD
25  2017 Effect of Resistance Exercise on Muscle Metabolism and Autophagy in sIBM. RE, RV
26  2017 Modeling functional decline over time in sporadic inclusion body myositis. 6MWT
27  2017 Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis. cN1A, IgG
28  2017 Physical function and muscle strength in sporadic inclusion body myositis. 2MWT, TUG
29  2017 Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts. DM, NT5C1A, PM, SARDs, SLE, SS, SSc
30  2017 Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis. RVs
31  2017 Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis. DM, IF1, IMs, PKM2, PM, RPPA
32  2017 Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy. ---
33  2017 The role of p62/SQSTM1 in sporadic inclusion body myositis. S403-pp62
34  2017 Transforming growth factor-beta signaling is upregulated in sporadic inclusion body myositis. DM, pSmad2, TbetaRI, TbetaRII, TGF-beta
35  2016 A Rare Case of Sporadic Inclusion Body Myositis (s-IBM). ---
36  2016 BACE-1, PS-1 and sAPPbeta Levels Are Increased in Plasma from Sporadic Inclusion Body Myositis Patients: Surrogate Biomarkers among Inflammatory Myopathies. BACE1, ELISA, FGF-21, HPLC, IL, mtDNA, PS1, sAPPbeta, TNF
37  2016 Clinical and Electrophysiological Findings in Hereditary Inclusion Body Myopathy Compared With Sporadic Inclusion Body Myositis. HIBM
38  2016 Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis. ---
39  2016 Development of the sporadic inclusion body myositis physical functioning assessment. FDA, PRO
40  2016 Effects of blood-flow-restricted resistance training on muscle function in a 74-year-old male with sporadic inclusion body myositis: a case report. BFR
41  2016 Idiopathic Inflammatory Myopathies: Clinical Approach and Management. CK, DM, IIM, MSA, NAM, PM
42  2016 Intramuscular dissociation of echogenicity in the triceps surae characterizes sporadic inclusion body myositis. DM, EIs, FCU, FDP, PM
43  2016 Mitochondrial DNA disturbances and deregulated expression of oxidative phosphorylation and mitochondrial fusion proteins in sporadic inclusion body myositis. MRC, mtDNA, PBMCs
44  2016 Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA. CODs
45  2016 Multicenter questionnaire survey for sporadic inclusion body myositis in Japan. ---
46  2016 Psychometric validation of a patient-reported measure of physical functioning in sporadic inclusion body myositis. sIFA
47  2016 Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis. SQSTM1, VCP
48  2016 Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement. MRC
49  2016 Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset. ---
50  2016 Sporadic inclusion-body myositis: Recent advances and the state of the art in 2016. ---
51  2016 Targeting protein homeostasis in sporadic inclusion body myositis. VCP
52  2015 Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy. ATF4, ER, UPR
53  2015 Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. ---
54  2015 Clinicopathologic features of sporadic inclusion body myositis in China. ---
55  2015 Discovery of new biomarkers of idiopathic inflammatory myopathy. DM, IIMs, IMNM, JIM, PM
56  2015 Effects of long-term resistance exercise training on autophagy in rat skeletal muscle of chloroquine-induced sporadic inclusion body myositis. CQ
57  2015 Genetic advances in sporadic inclusion body myositis. mtDNA
58  2015 High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study. ENMC, ICD-10
59  2015 Hypokalemia-Induced Rhabdomyolysis by Primary Aldosteronism Coexistent With Sporadic Inclusion Body Myositis. PA
60  2015 Incidence and prevalence of inflammatory myopathies: a systematic review. IMs
61  2015 Insights into muscle degeneration from heritable inclusion body myopathies. IBM
62  2015 Lower extremity peak force and gait kinematics in individuals with inclusion body myositis. LE
63  2015 Mitochondrial and inflammatory changes in sporadic inclusion body myositis. ---
64  2015 Novel serology testing for sporadic inclusion body myositis: disease-specificity and diagnostic utility. cN1A
65  2015 Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients. ---
66  2015 Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy. ---
67  2015 Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort. DM, ENMC, IIM, PM, SMR
68  2015 Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis. IBM, PDB
69  2015 The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis. APOE, TOMM40, VL
70  2014 Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis. hnRNP
71  2014 Autophagy, inflammation and innate immunity in inflammatory myopathies. DM, HMGB1, IIMs, JDM, PM
72  2014 Cellular nucleic acid binding protein suppresses tumor cell metastasis and induces tumor cell death by downregulating heterogeneous ribonucleoprotein K in fibrosarcoma cells. CD, CNBP, DM2, EMSA, FRET, hnRNP K, ITC, SPR, TMPyP4
73  2014 Clinical features of Japanese patients with inclusion body myositis. ---
74  2014 Contrasting echogenicity in flexor digitorum profundus-flexor carpi ulnaris: a diagnostic ultrasound pattern in sporadic inclusion body myositis. ALS, EI, FCU, FDP, US
75  2014 Diagnosis and classification of sporadic inclusion body myositis (sIBM). ---
76  2014 Functional impairment in patients with sporadic Inclusion Body Myositis. CK
77  2014 Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis. COX, COX, mtDNA
78  2014 Human beta-defensin-3 correlates with muscle fibre degeneration in idiopathic inflammatory myopathies. hBD, IIM, PM
79  2014 Idiopathic inflammatory myopathies. CTDs, DM, IIMs, PM
80  2014 Invasive fibroblasts: fundamental difference between sporadic inclusion body myositis and polymyositis. ---
81  2014 Phosphorylation of NBR1 by GSK3 modulates protein aggregation. GSK-3
82  2014 Proteomic study of sporadic inclusion body myositis. APP
83  2014 Risk factors for osteoporosis, falls and fractures in hereditary myopathies and sporadic inclusion body myositis - A cross sectional survey. FSHD, OPMD
84  2014 Sodium phenylbutyrate reverses lysosomal dysfunction and decreases amyloid-beta42 in an in vitro-model of inclusion-body myositis. ---
85  2014 Sporadic inclusion body myositis: the genetic contributions to the pathogenesis. ---
86  2014 Th1 response and systemic treg deficiency in inclusion body myositis. ---
87  2014 Treatment of sporadic inclusion body myositis with bimagrumab. ActRII
88  2014 Validity of the single limb heel raise test to predict lower extremity disablement in patients with sporadic inclusion body myositis. SLHR, SLHR
89  2014 Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy. ---
90  2014 [Inclusion-body myositis]. ---
91  2014 [Recent progress in diagnosis and pathomechanism of inclusion body myositis]. cN1A
92  2014 [Sporadic inclusion body myositis and amyloid]. ---
93  2014 [The etiology and pathogenesis of sporadic inclusion body myositis]. ---
94  2013 A ketogenic diet improves motor performance but does not affect beta-amyloid levels in a mouse model of Alzheimer's disease. AD, CTFbeta
95  2013 A rare association of early-onset inclusion body myositis, rheumatoid arthritis and autoimmune thyroiditis: a case report and literature review. ---
96  2013 Asymptomatic hyper-creatine-kinase-emia as sole manifestation of inclusion body myositis. ---
97  2013 Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis. cN1A
98  2013 Balloon dilation in sporadic inclusion body myositis patients with Dysphagia. CPM, UES, VF
99  2013 Beyond the binding site: in vivo identification of tbx2, smarca5 and wnt5b as molecular targets of CNBP during embryonic development. DM2
100  2013 Cell stress molecules in the skeletal muscle of GNE myopathy. APP, IL, iNOS, MHC, NCAM, P-neurofilament